NYSE:PKI (USA) Also trade in: Germany UK

PerkinElmer Inc

$ 95.1 0 (0%)
Volume: 413,436 Avg Vol (1m): 879,744
Market Cap $: 10.55 Bil Enterprise Value $: 12.28 Bil
P/E (TTM): 42.84 P/B: 4.01
Earnings Power Value 16.72
Net Current Asset Value -19.77
Tangible Book -13.19
Projected FCF 43.98
Median P/S Value 54.77
Graham Number 0
Peter Lynch Value 25.91
DCF (FCF Based) 26.61
DCF (Earnings Based) 58.38
1Y (-%)

Financial Strength : 5.6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.07
Cash-To-Debt range over the past 10 years
Min: 0.07, Med: 0.35, Max: 2.06
Current: 0.07
0.07
2.06
Equity-to-Asset 0.43
Equity-to-Asset range over the past 10 years
Min: 0.24, Med: 0.52, Max: 0.63
Current: 0.43
0.24
0.63
Debt-to-Equity 0.71
Debt-to-Equity range over the past 10 years
Min: 0.1, Med: 0.38, Max: 1.61
Current: 0.71
0.1
1.61
Debt-to-EBITDA 3.60
Debt-to-EBITDA range over the past 10 years
Min: 1.57, Med: 3.31, Max: 4.72
Current: 3.6
1.57
4.72
Interest Coverage 5.36
Interest Coverage range over the past 10 years
Min: 4.34, Med: 6.1, Max: 11.11
Current: 5.36
4.34
11.11
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.18
DISTRESS
GREY
SAFE
Beneish M-Score -2.47
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 7.44%
WACC 9.55%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 12.56
Operating Margin range over the past 10 years
Min: 5.61, Med: 11.22, Max: 14.17
Current: 12.56
5.61
14.17
Net Margin % 8.89
Net Margin range over the past 10 years
Min: 0.4, Med: 8.16, Max: 22.98
Current: 8.89
0.4
22.98
ROE % 9.61
ROE range over the past 10 years
Min: 0.41, Med: 8.93, Max: 22
Current: 9.61
0.41
22
ROA % 4.12
ROA range over the past 10 years
Min: 0.22, Med: 4.1, Max: 12.48
Current: 4.12
0.22
12.48
ROC (Joel Greenblatt) % 50.51
ROC (Joel Greenblatt) range over the past 10 years
Min: 26.99, Med: 51.1, Max: 76.53
Current: 50.51
26.99
76.53
3-Year Total Revenue Growth Rate 9.70
3-Year Revenue Growth Rate range over the past 10 years
Min: -21, Med: 0.7, Max: 20.5
Current: 10.3
-21
20.5
3-Year Total EBITDA Growth Rate 12.80
3-Year EBITDA Growth Rate range over the past 10 years
Min: -15.5, Med: 5.2, Max: 35.4
Current: 13.4
-15.5
35.4
3-Year EPS w/o NRI Growth Rate 8.40
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 5.8, Max: 384.9
Current: 8.4
0
384.9

» PKI's 30-Y Financials

Financials (Next Earnings Date: 2019-07-29)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:PKI

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Medical Diagnostics & Research    NAICS : 334516    SIC : 8071
Compare XPAR:BIM NYSE:BIO.B NYSE:QGEN NAS:ICLR XTER:SRT XPAR:ERF NAS:BRKR TSE:6869 NAS:DXCM NYSE:DGX NAS:GH SHSE:603259 NYSE:CRL NAS:PRAH NYSE:WAT MIL:DIA NAS:EXAS NAS:SYNH NYSE:LH SHSE:603658
Traded in other countries PKN.Germany 0KHE.UK
Address 940 Winter Street, Waltham, MA, USA, 02451
PerkinElmer provides instruments, consumables, and services to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.

Ratios

Current vs industry vs history
PE Ratio (TTM) 42.84
PE Ratio range over the past 10 years
Min: 5.3, Med: 28.45, Max: 3165
Current: 42.84
5.3
3165
Forward PE Ratio 23.64
N/A
PE Ratio without NRI 42.84
PE without NRI range over the past 10 years
Min: 11.52, Med: 29.55, Max: 2724
Current: 42.84
11.52
2724
Price-to-Owner-Earnings 40.64
Price-to-Owner-Earnings range over the past 10 years
Min: 4.69, Med: 24.81, Max: 38590
Current: 40.64
4.69
38590
PB Ratio 4.01
PB Ratio range over the past 10 years
Min: 0.88, Med: 2.33, Max: 4.22
Current: 4.01
0.88
4.22
PS Ratio 3.81
PS Ratio range over the past 10 years
Min: 0.72, Med: 2.2, Max: 4.07
Current: 3.81
0.72
4.07
Price-to-Free-Cash-Flow 47.22
Price-to-Free-Cash-Flow range over the past 10 years
Min: 7.76, Med: 22.82, Max: 93.47
Current: 47.22
7.76
93.47
Price-to-Operating-Cash-Flow 33.15
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 6.28, Med: 19.64, Max: 42.78
Current: 33.15
6.28
42.78
EV-to-EBIT 37.08
EV-to-EBIT range over the past 10 years
Min: 10.5, Med: 29.85, Max: 59.2
Current: 37.08
10.5
59.2
EV-to-EBITDA 23.71
EV-to-EBITDA range over the past 10 years
Min: 6.9, Med: 19, Max: 26.1
Current: 23.71
6.9
26.1
EV-to-Revenue 4.41
EV-to-Revenue range over the past 10 years
Min: 0.9, Med: 2.5, Max: 4.9
Current: 4.41
0.9
4.9
PEG Ratio 3.79
PEG Ratio range over the past 10 years
Min: 1.53, Med: 2.65, Max: 29.96
Current: 3.79
1.53
29.96
Shiller PE Ratio 53.21
Shiller PE Ratio range over the past 10 years
Min: 14.4, Med: 30.78, Max: 56.55
Current: 53.21
14.4
56.55
Current Ratio 1.68
Current Ratio range over the past 10 years
Min: 0.74, Med: 1.69, Max: 2.59
Current: 1.68
0.74
2.59
Quick Ratio 1.17
Quick Ratio range over the past 10 years
Min: 0.54, Med: 1.24, Max: 2.09
Current: 1.17
0.54
2.09
Days Inventory 92.69
Days Inventory range over the past 10 years
Min: 74.6, Med: 82.55, Max: 92.69
Current: 92.69
74.6
92.69
Days Sales Outstanding 81.84
Days Sales Outstanding range over the past 10 years
Min: 71.98, Med: 78.47, Max: 89.32
Current: 81.84
71.98
89.32
Days Payable 56.13
Days Payable range over the past 10 years
Min: 45.11, Med: 56.03, Max: 68.51
Current: 56.13
45.11
68.51

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.29
Trailing Dividend Yield range over the past 10 years
Min: 0.28, Med: 0.67, Max: 2.43
Current: 0.29
0.28
2.43
Dividend Payout Ratio 0.13
Dividend Payout Ratio range over the past 10 years
Min: 0.13, Med: 0.22, Max: 28
Current: 0.13
0.13
28
Forward Dividend Yield % 0.29
N/A
Yield-on-Cost (5-Year) % 0.29
Yield-on-Cost (5y) range over the past 10 years
Min: 0.28, Med: 0.67, Max: 2.43
Current: 0.29
0.28
2.43
3-Year Share Buyback Rate 0.20
3-Year Share Buyback Rate range over the past 10 years
Min: -10.7, Med: 0.7, Max: 8.1
Current: 0.2
-10.7
8.1

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.16
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.52, Med: 1.34, Max: 70.89
Current: 2.16
0.52
70.89
Price-to-DCF (Earnings Based) 1.63
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 1.4, Med: 2.63, Max: 3.4
Current: 1.63
1.4
3.4
Price-to-Median-PS-Value 1.74
Price-to-Median-PS-Value range over the past 10 years
Min: 0.14, Med: 0.69, Max: 1.86
Current: 1.74
0.14
1.86
Price-to-Peter-Lynch-Fair-Value 3.67
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.73, Med: 3.16, Max: 20.93
Current: 3.67
0.73
20.93
Earnings Yield (Joel Greenblatt) % 2.70
Earnings Yield (Greenblatt) range over the past 10 years
Min: 1.7, Med: 3.35, Max: 9.5
Current: 2.7
1.7
9.5
Forward Rate of Return (Yacktman) % 13.94
Forward Rate of Return range over the past 10 years
Min: -3.9, Med: 13.4, Max: 19.3
Current: 13.94
-3.9
19.3

More Statistics

Revenue (TTM) (Mil) $ 2,782.76
EPS (TTM) $ 2.22
Beta 1.46
Volatility % 32.87
52-Week Range $ 71.83 - 103
Shares Outstanding (Mil) 110.6

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N